209 related articles for article (PubMed ID: 5591688)
1. [Combined chemo-radiotherapeutic treatment of breast neoplasms at the metastatis stage].
Agati G; Stoppa IM
J Radiol Electrol Med Nucl; 1967 Nov; 48(11):803-4. PubMed ID: 5591688
[No Abstract] [Full Text] [Related]
2. [Combined chemo-radiotherapeutic treatment of breast cancer in an advanced stage].
Agati G; Stoppa IM
Minerva Radiol; 1967 Sep; 12(9):323-4. PubMed ID: 5615839
[No Abstract] [Full Text] [Related]
3. [Endocrine and cytostatic treatment of metastazing breast carcinoma in the female].
Nowakowski H
Strahlentherapie; 1974 Apr; 147(4):388-400. PubMed ID: 4409449
[No Abstract] [Full Text] [Related]
4. [Combined chemotherapy in metastatic breast cancer].
Haab OP
Praxis; 1967 Jun; 56(25):873-4. PubMed ID: 5632944
[No Abstract] [Full Text] [Related]
5. [Highly promising new therapeutic agents. Bisphosphonate and erythropoietin in radiotherapy].
Radiologe; 1999 Mar; 39(3 Suppl):1-3. PubMed ID: 10231898
[No Abstract] [Full Text] [Related]
6. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
Naumann R
Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
[No Abstract] [Full Text] [Related]
7. [Therapy of advanced mammary carcinomas with high-dosed cytostatics].
Boeckl O; Heitz N; Wasl H; Karrer K; Mannheimer E
Munch Med Wochenschr; 1965 Oct; 107(43):2114-8. PubMed ID: 5899028
[No Abstract] [Full Text] [Related]
8. Radiotherapy of metastases of mammary carcinoma.
Thomas P
Radiol Clin (Basel); 1976; 45(2-4):306-13. PubMed ID: 59936
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer 1984: state of the art.
Sledge GW
Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
[No Abstract] [Full Text] [Related]
10. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
Sanuki-Fujimoto N
Cancer Treat Rev; 2005 Oct; 31(6):496-500. PubMed ID: 16199127
[No Abstract] [Full Text] [Related]
11. [Cytostatic chemotherapy in the treatment of malignant tumors].
Langhammer H; Klemm J; Pabst HW
Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
[No Abstract] [Full Text] [Related]
12. [Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
Brunner KW
Schweiz Med Wochenschr; 1969 Sep; 99(36):1298-303. PubMed ID: 5351150
[No Abstract] [Full Text] [Related]
13. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
Mannes P; Derriks R
Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
[No Abstract] [Full Text] [Related]
14. The phase II study: some reflections, particularly concerning disseminated breast cancer.
Ahmann DL
Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
[No Abstract] [Full Text] [Related]
15. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
Smalley RV; Bartolucci AA
Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
[No Abstract] [Full Text] [Related]
16. [Findings and considerations on 118 cases of reticulohistiocytomas in different sites].
Marrocu F; Deplano A
Nunt Radiol; 1967; 33():Suppl:524-36. PubMed ID: 4308221
[No Abstract] [Full Text] [Related]
17. [Cytostatic therapy of metastatic breast cancer].
Mussa A; Dogliotti L; Musumeci SV; Linfanti CV; Alabiso O; Festa V; Giugno G; Sandrucci S; Benedetto G
Minerva Chir; 1980 Aug 15-31; 35(15-16):1195-225. PubMed ID: 7005745
[TBL] [Abstract][Full Text] [Related]
18. [Effect of estrogen-gestagen combination therapy in advanced breast carcinoma with special reference to pulmonary metastases].
Berndt G; Eckel H; Notter G; St Stender H
Strahlentherapie; 1971 May; 141(5):540-8. PubMed ID: 5088730
[No Abstract] [Full Text] [Related]
19. [Prevention of breast cancer recurrence--cytostatic agents].
Karrer K
Wien Klin Wochenschr; 1970 Jun; 82(25):465-7. PubMed ID: 5523880
[No Abstract] [Full Text] [Related]
20. Relevance of the occult metastasis existing at the time of surgical intervention as a target for a chemotherapeutic treatment.
Peek U; Marx G; Greiner P; Seifart W; Tanneberger S
Arch Geschwulstforsch; 1978; 48(7):616-26. PubMed ID: 736742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
